Eligibility and Projected Benefits of Rapid Initiation of Quadruple Medical Therapy for Newly Diagnosed Heart Failure

By sjmartinez • April 11, 2024

Greene SJ, Ayodele I, Pierce JB, Khan MS, Lewsey SC, Yancy CW, Alhanti B, Van Spall HGC, Allen LA, Fonarow GC. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Medical Therapy for Newly Diagnosed Heart Failure. JACC Heart Fail. 2024 Mar 25:S2213-1779(24)00244-0. doi: 10.1016/j.jchf.2024.03.001. Epub ahead of print. PMID: 38597866.

Tags: Cardiology/Epi, heart failure, Hospitalization, medication, Publications, quadruple therapy

Premature Ventricular Contractions Ablated via the Left Ventricular Annular Vein: Demonstration of 3 Possible Approaches

Kanzaki Y, Morishima I, Mori S, Shimojo K, Tanaka Y, Yamada T. Premature Ventricular Contractions Ablated via the Left Ventricular Annular Vein: Demonstration of 3[...]

Building Resilience in Academic Science and Medicine

Nguyen PK, Rodriguez-Miguelez P, Alfaidi M, Erbay E, Freed J, Hansen L, Kassiri Z, Lu HS, Oliveira SD, Wu AW, Zhang H, Chen ZB; ATVB[...]

The association of eicosanoids with lung structure and function: Findings from the Multi-Ethnic Study of Atherosclerosis lung study and Framingham Heart Study

Ambatipudi M, McNeill JN, Roshandelpoor A, Alotaibi M, Mounsey LA, Hoffman E, O'Connor G, Choi SH, Allen NB, Barr RG, Jain M, Cheng S, Ho[...]